Alerus Financial NA Takes $205,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Alerus Financial NA purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, Holdings Channel reports. The fund purchased 1,405 shares of the financial services provider’s stock, valued at approximately $205,000.

A number of other institutional investors have also added to or reduced their stakes in IBB. FSA Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter worth about $65,000. Erste Asset Management GmbH bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $5,678,000. Tradition Wealth Management LLC increased its stake in shares of iShares Biotechnology ETF by 3.3% in the third quarter. Tradition Wealth Management LLC now owns 55,847 shares of the financial services provider’s stock valued at $8,131,000 after buying an additional 1,790 shares during the period. Walleye Capital LLC increased its stake in shares of iShares Biotechnology ETF by 82.7% in the third quarter. Walleye Capital LLC now owns 9,018 shares of the financial services provider’s stock valued at $1,313,000 after buying an additional 4,082 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at approximately $2,941,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB opened at $141.55 on Monday. iShares Biotechnology ETF has a fifty-two week low of $119.95 and a fifty-two week high of $150.57. The company’s 50 day moving average price is $142.71 and its two-hundred day moving average price is $142.06.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.